Report Scope: This report will provide a detailed look at the pulmonary drug delivery systems market, highlighting major pulmonary diseases with detailed epidemiology for major disease areas such as asthma, COPD and cystic fibrosis. The report includes an industry-wide assessment of the novel products, launches, recent approvals, research and development pipeline, and blockbuster drugs.
In the report the regulatory scenario of pulmonary drug delivery systems is discussed for device type.This will include products approved by regulatory authorities in recent years.
Products under development or in different stages of clinical trials are analyzed in the Pipeline Analysis section.
A discussion of the major players is included in the Competitive Landscape section.The Competitive Landscape section provides trends in product launch, collaborations, mergers and acquisitions, and other agreements.
Company profiles of major players operating in the pulmonary drug delivery systems market are included with an overview, key product offerings, financials, strategies, strength, weakness, opportunities and threats (SWOT) and developments. The report will be useful for analysis of the leading products and will enable readers to recognize growing brands, key device types and leading manufacturing companies with significant market share.
Report Includes: - 74 tables - A detailed overview and analysis of the global markets for pulmonary drug delivery systems - Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022 - Assessments of pulmonary drug delivery systems by regions, delivery systems/types, and disease areas - A look at the regulatory environment, which has been a driving force in the healthcare industry - Reviews of key developments, novel product innovations, and recent strategic industry activities of major players across various product categories - Detailed profiles of major vendors in the market, including 3M Pharmaceuticals Inc., AstraZeneca plc, Cipla Inc., GlaxoSmithKline plc and Lupin Ltd
Summary Pulmonary drug delivery is an alternative to oral drug delivery.Pulmonary drug delivery is primarily advantageous for the treatment of respiratory diseases due to systemic administration via fast absorption by the alveolar region.
The pulmonary drug delivery method depends on the development of simple, cost effective and easy to use devices.These devices are designed to facilitate consistent drug delivery with increased lung penetration and multi-dosage facilities.
Currently, manufacturers are concentrating on the development of small, portable devices that encourage higher patient compliance. The World Health Organization (WHO) estimates that there were approximately 251 million people suffering from COPD globally in 2016. It is estimated by the WHO that nearly 3.17 million deaths occurred in 2015 due to the disease itself. The primary cause of the disease is smoking tobacco. The growing number of smokers in developing economies is increasing the incidence of the disease.
The market for pulmonary drug delivery systems is witnessing growth due to the rising prevalence of respiratory disorders such as asthma, COPD and other chronic illnesses. Other factors that are driving the growth of themarket are the emergence of novel inhaler designs and increased use of non-invasive drug delivery methods.
The pulmonary drug delivery systems market is estimated at REDACTED in 2017, growing at acompound annual growth rate (CAGR) of REDACTED to reach REDACTED in 2022.
Our reports have been used by over 10K customers, including:
Pulmonary Drug Delivery Systems market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Pulmonary Drug Delivery Systems Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Pulmonary Drug Delivery Systems types,...
The Global Drug Delivery Partnering Terms and Agreements 2014-2021 report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies. This report provides details of the latest Drug Delivery agreements announced...
The global styrenic block copolymer market grew at a CAGR of around 7% during 2015-2020. Styrenic block copolymers (SBCs) which combine the properties of a thermoplastic resin and an elastomer, are a type of block copolymers having an elastomeric central arrangement and polystyrene based end-segments. The central blocks...
The global chondroitin sulfate market grew at a CAGR of around 4% during 2015-2020. Chondroitin sulfate (CS) is a water-soluble polymer comprising alternating N-Acetylgalactosamine and glucuronic acid, which is naturally found in the cartilage, bone and cornea of animals. CS (C6H13NO5) is anti-atherogenic, inflammatory,...
The global nanomedicine market exhibited strong growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 10% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic...
The global transdermal drug delivery systems market exhibited moderate growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...
The global wearable injectors market exhibited strong growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 15% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...
272 pages •
By The Business Research Company
• Oct 2021
Drug Delivery Devices Global Market Opportunities And Strategies To 2030: COVID 19 Implications And Growth provides the strategists, marketers and senior management with the critical information they need to assess the global drug delivery devices market as it emerges from the COVID 19 shut down. Description: Where...
Medical Tubing Market Size, Share & Trends Analysis Report By Product (Fluoropolymers, PVC), By Application (Bulk Disposable Tubing, Drug Delivery Systems), By Region (APAC, North America), And Segment Forecasts, 2020 - 2028 Medical Tubing Market Growth & Trends The global medical tubing...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.